1. Home
  2. XPL vs ICCC Comparison

XPL vs ICCC Comparison

Compare XPL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.74

Market Cap

64.6M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.73

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPL
ICCC
Founded
1984
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.6M
55.5M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
XPL
ICCC
Price
$0.74
$6.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.20
N/A
AVG Volume (30 Days)
228.6K
37.3K
Earning Date
10-31-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
N/A
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$25.64
Revenue Growth
N/A
16.49
52 Week Low
$0.54
$4.28
52 Week High
$0.90
$7.60

Technical Indicators

Market Signals
Indicator
XPL
ICCC
Relative Strength Index (RSI) N/A 63.61
Support Level N/A $6.15
Resistance Level N/A $6.89
Average True Range (ATR) 0.00 0.37
MACD 0.00 0.04
Stochastic Oscillator 0.00 64.39

Price Performance

Historical Comparison
XPL
ICCC

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: